Estradiol-activated estrogen receptor α does not regulate mature microRNAs in T47D breast cancer cells

Anne Katchy1, Karin Edvardsson, Eylem Aydogdu

  • 1Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX, USA.

Insights

This study investigated how estrogen affects microRNAs (miRNAs) in breast cancer cells. Researchers found that while estrogen significantly alters protein-coding genes, it does not appear to change mature miRNA expression levels.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Breast cancers often exhibit hormone sensitivity, particularly to estrogen.
  • Estrogen receptor (ER) activation by estrogen influences gene expression, impacting cell behavior.
  • MicroRNAs (miRNAs) are key regulators of gene expression, crucial for understanding cancer development.

Purpose of the Study:

  • To identify specific miRNAs regulated by estrogen receptor alpha (ERα) activation.
  • To investigate the role of miRNAs in estrogen-mediated gene regulation in breast cancer.
  • To clarify conflicting previous findings on miRNA involvement in ER-positive breast cancers.

Main Methods:

  • Utilized T47D breast cancer cells treated with 17β-estradiol (E2) to activate ERα.
  • Employed dual-color microarrays and TaqMan Low Density Arrays for miRNA expression analysis.
  • Validated findings using real-time polymerase chain reaction (PCR).

Main Results:

  • Estrogen treatment led to significant alterations in the expression of numerous protein-coding genes.
  • No significant changes were confirmed in the expression levels of mature miRNAs.
  • This contrasts with the substantial changes observed in protein-coding gene expression.

Conclusions:

  • ERα activation by estrogen significantly impacts protein-coding gene expression but not mature miRNA levels in T47D cells.
  • The study provides a comprehensive analysis of ERα-mediated miRNA regulation.
  • Findings contribute to a clearer understanding of estrogen signaling pathways in breast cancer.